Published in Dev Psychopathol on January 01, 2000
Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci (2011) 2.89
Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet (2013) 1.96
A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol Psychiatry (2006) 1.93
Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort. Arch Gen Psychiatry (2010) 1.85
Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res (2010) 1.83
Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets (2006) 1.78
White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis. Biol Psychiatry (2009) 1.65
Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia. J Neurosci (2011) 1.61
Variance of gene expression identifies altered network constraints in neurological disease. PLoS Genet (2011) 1.53
The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl) (2003) 1.49
Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psychiatry (2010) 1.36
Analyzing schizophrenia by DNA microarrays. Biol Psychiatry (2011) 1.16
Diagnostic and sex effects on limbic volumes in early-onset bipolar disorder and schizophrenia. Schizophr Bull (2007) 1.15
The impact of maternal separation on adult mouse behaviour and on the total neuron number in the mouse hippocampus. Brain Struct Funct (2008) 1.12
Synaptic changes in the brain of subjects with schizophrenia. Int J Dev Neurosci (2011) 1.11
Social predictors of psychotic experiences: specificity and psychological mechanisms. Schizophr Bull (2008) 1.10
The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry (2002) 1.09
Minor physical anomalies in schizophrenia: a meta-analysis. Schizophr Res (2006) 1.08
Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. PLoS One (2012) 1.07
Decreased mRNA expression of netrin-G1 and netrin-G2 in the temporal lobe in schizophrenia and bipolar disorder. Neuropsychopharmacology (2007) 1.04
Emotion recognition in individuals at clinical high-risk for schizophrenia. Schizophr Bull (2011) 1.04
HLA-B maternal-fetal genotype matching increases risk of schizophrenia. Am J Hum Genet (2006) 1.04
The complement system in schizophrenia. Drug News Perspect (2008) 1.02
Immature dentate gyrus: an endophenotype of neuropsychiatric disorders. Neural Plast (2013) 1.01
Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia. Neurotox Res (2008) 0.99
Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia. Mol Brain (2014) 0.96
Neurodevelopment, GABA system dysfunction, and schizophrenia. Neuropsychopharmacology (2014) 0.96
Fronto-temporal dysfunction in schizophrenia: A selective review. Indian J Psychiatry (2009) 0.96
CHL1 is a selective organizer of the presynaptic machinery chaperoning the SNARE complex. PLoS One (2010) 0.93
DISC1 is associated with cortical thickness and neural efficiency. Neuroimage (2011) 0.91
Dynamics of subcellular proteomes during brain development. J Proteome Res (2012) 0.91
Postmortem brain: an underutilized substrate for studying severe mental illness. Neuropsychopharmacology (2013) 0.91
Schizophrenic autism: clinical phenomenology and pathogenetic implications. World Psychiatry (2002) 0.91
Update on the neurobiology of schizophrenia: a role for extracellular microdomains. Minerva Psichiatr (2012) 0.91
Infragranular gene expression disturbances in the prefrontal cortex in schizophrenia: signature of altered neural development? Neurobiol Dis (2009) 0.90
Altered serine/threonine kinase activity in schizophrenia. Brain Res (2014) 0.88
Predictors of psychosis: a 50-year follow-up of the Lundby population. Eur Arch Psychiatry Clin Neurosci (2009) 0.87
Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings. Child Adolesc Psychiatr Clin N Am (2013) 0.86
Should cognitive deficit be a diagnostic criterion for schizophrenia? J Psychiatry Neurosci (2004) 0.86
PRENATAL INFECTION, MATERNAL IMMUNE ACTIVATION, AND RISK FOR SCHIZOPHRENIA. Transl Neurosci (2012) 0.86
Loss of function studies in mice and genetic association link receptor protein tyrosine phosphatase α to schizophrenia. Biol Psychiatry (2011) 0.85
Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models. Front Behav Neurosci (2013) 0.85
Using latent class growth analysis to form trajectories of premorbid adjustment in schizophrenia. J Abnorm Psychol (2012) 0.84
Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia. J Biomed Biotechnol (2010) 0.84
Schizophrenia and neural tube defects: comparisons from an epidemiological perspective. Schizophr Bull (2006) 0.83
Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia. PLoS One (2010) 0.82
Shared and nonshared symptoms in youth-onset psychosis and ADHD. J Atten Disord (2009) 0.82
Abnormalities in hemispheric specialization of caudate nucleus connectivity in schizophrenia. JAMA Psychiatry (2015) 0.82
Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats. Mol Psychiatry (2014) 0.82
Frequency and pattern of childhood symptom onset reported by first episode schizophrenia and clinical high risk youth. Schizophr Res (2014) 0.81
Approaches for adolescents with an affected family member with schizophrenia. Curr Psychiatry Rep (2004) 0.80
Using model systems to understand errant plasticity mechanisms in psychiatric disorders. Nat Neurosci (2016) 0.80
Raising attention to attention deficit hyperactivity disorder in schizophrenia. World J Psychiatry (2015) 0.80
Perinatal phencyclidine administration decreases the density of cortical interneurons and increases the expression of neuregulin-1. Psychopharmacology (Berl) (2013) 0.79
Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid. Brain Behav Immun (2013) 0.79
Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex. Int J Neuropsychopharmacol (2014) 0.78
Stereological assessment of the dorsal anterior cingulate cortex in schizophrenia: absence of changes in neuronal and glial densities. Neuropathol Appl Neurobiol (2013) 0.78
Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia. J Neurosci Res (2011) 0.78
Injections of NGF into neonatal frontal cortex decrease social interaction as adults: a rat model of schizophrenia. Schizophr Bull (2007) 0.77
Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17. Psychopharmacology (Berl) (2007) 0.77
Associating schizophrenia, long non-coding RNAs and neurostructural dynamics. Front Mol Neurosci (2015) 0.77
Common variants in the MKL1 gene confer risk of schizophrenia. Schizophr Bull (2014) 0.76
Effects of nicotine on quinpirole- and dizocilpine (MK-801)-induced sensorimotor gating impairments in rats. Psychopharmacology (Berl) (2008) 0.76
A developmental look at the attentional system in the at risk and first episode of psychosis: age related changes in attention along the psychosis spectrum. Cogn Neuropsychiatry (2012) 0.76
Histamine H3 receptors and its antagonism as a novel mechanism for antipsychotic effect: a current preclinical & clinical perspective. Int J Health Sci (Qassim) (2016) 0.75
Uniting the neuro developmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia. Sci Rep (2017) 0.75
Mother-infant interaction in schizophrenia: transmitting risk or resilience? A systematic review of the literature. Soc Psychiatry Psychiatr Epidemiol (2015) 0.75
Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia. Mol Psychiatry (2017) 0.75
Genomic Editing of Non-Coding RNA Genes with CRISPR/Cas9 Ushers in a Potential Novel Approach to Study and Treat Schizophrenia. Front Mol Neurosci (2017) 0.75
Functional genomics indicate that schizophrenia may be an adult vascular-ischemic disorder. Transl Psychiatry (2015) 0.75
Theranostic Biomarkers for Schizophrenia. Int J Mol Sci (2017) 0.75
Contribution of nonprimate animal models in understanding the etiology of schizophrenia. J Psychiatry Neurosci (2011) 0.75
Episodic memory functions in first episode psychosis and clinical high risk individuals. Schizophr Res (2017) 0.75
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A (2001) 9.42
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 9.23
Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry (1987) 8.81
Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry (1986) 4.34
Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex (2000) 3.37
Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex (1999) 3.31
Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med (1990) 3.10
Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry (1990) 3.07
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A (1997) 3.00
Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry (2001) 2.80
Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry (2000) 2.62
Noise reduction in 3D perfusion imaging by attenuating the static signal in arterial spin tagging (ASSIST). Magn Reson Med (2000) 2.58
Neurophysiological correlates of age-related changes in human motor function. Neurology (2002) 2.52
Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry (1997) 2.48
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry (2000) 2.32
Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology (2000) 2.28
Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry (1987) 2.24
Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry (2006) 2.22
H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med (2000) 2.20
Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci U S A (1997) 2.19
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry (2003) 2.18
Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry (2007) 2.12
Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry (2001) 2.08
Schizophrenia and temporal lobe epilepsy. A neuropsychological analysis. Arch Gen Psychiatry (1994) 2.07
Relative risk of attention deficits in siblings of patients with schizophrenia. Am J Psychiatry (2000) 2.07
Genetic contributions to regional variability in human brain structure: methods and preliminary results. Neuroimage (2002) 2.01
Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology (1993) 1.99
Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch Gen Psychiatry (1979) 1.94
Genetic variability of human brain size and cortical gyral patterns. Brain (1997) 1.92
Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol (1992) 1.91
Cognitive substrates of thought disorder, I: the semantic system. Am J Psychiatry (1998) 1.90
To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology (2000) 1.89
Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res (2001) 1.85
Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry (1993) 1.78
The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry (1993) 1.75
Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience (2003) 1.74
Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol Psychiatry (2008) 1.70
Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry (2008) 1.66
Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia (1995) 1.65
COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET. Mol Psychiatry (2008) 1.63
Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage (2000) 1.63
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry (2004) 1.62
Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn Reson Med (1997) 1.61
The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biol Psychiatry (1999) 1.60
Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. Arch Gen Psychiatry (1988) 1.58
GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry (2005) 1.56
Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology (1998) 1.54
Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Mol Psychiatry (2007) 1.54
Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry (1993) 1.52
Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Mol Psychiatry (2008) 1.51
Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) (1995) 1.48
Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation. Br J Psychiatry (1993) 1.47
Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb Cortex (2006) 1.46
A comparison of rCBF patterns during letter and semantic fluency. Neuropsychology (2000) 1.45
Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia. Schizophr Res (2012) 1.44
Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry (1986) 1.42
MRI asymmetries of Broca's area: the pars triangularis and pars opercularis. Brain Lang (1998) 1.41
A quantitative analysis of smooth pursuit eye tracking in monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry (1997) 1.41
Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone. J Comp Neurol (2000) 1.40
Hemispheric control of motor function: a whole brain echo planar fMRI study. Psychiatry Res (1998) 1.38
Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol Psychiatry (2007) 1.38
Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice. Mol Psychiatry (2007) 1.32
Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins. Neurology (1992) 1.31
Reduced central serotonin transporters in alcoholism. Am J Psychiatry (1998) 1.31
Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia. Am J Psychiatry (2000) 1.31
Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer? Mol Psychiatry (2008) 1.30
Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology (Berl) (1997) 1.30
Dopamine, the prefrontal cortex and schizophrenia. J Psychopharmacol (1997) 1.30
Operant conditioning and the orbitofrontal cortex in schizophrenic patients: unexpected evidence for intact functioning. Schizophr Res (1998) 1.28
Workshop on schizophrenia. Proc Natl Acad Sci U S A (1997) 1.28
Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry (2000) 1.28
Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry (2005) 1.27
Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol Psychiatry (2006) 1.25
Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry (1996) 1.23
Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol Psychiatry (2003) 1.23
The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry (2001) 1.22
No difference in basal ganglia mineralization between schizophrenic and nonschizophrenic patients: a quantitative computerized tomographic study. Biol Psychiatry (1990) 1.21
Forms of memory failure in schizophrenia. J Abnorm Psychol (1992) 1.20
Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol Psychiatry (2010) 1.20
Assessment of procedural learning and problem solving in schizophrenic patients by Tower of Hanoi type tasks. J Neuropsychiatry Clin Neurosci (1990) 1.20
Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder. Schizophr Res (1995) 1.19
Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study. J Neurosci (1996) 1.18
Schizophrenia as a developmental disorder of the cerebral cortex. Curr Opin Neurobiol (1998) 1.17
The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci (1991) 1.17
Duration judgements in patients with schizophrenia. Psychol Med (2003) 1.16
Neurobiology of schizophrenia. Curr Opin Neurobiol (1997) 1.16
Cerebral morphometric abnormalities in Tourette's syndrome: a quantitative MRI study of monozygotic twins. Neurology (1995) 1.15
Neuropsychological performance of monozygotic twins discordant for bipolar disorder. Biol Psychiatry (1999) 1.14
The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology (2000) 1.14
Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science (1996) 1.13
Probing prefrontal function in schizophrenia with neuropsychological paradigms. Schizophr Bull (1988) 1.13
Proton MR spectroscopic imaging without water suppression. Radiology (2000) 1.13
Psychomotor slowing, negative symptoms and dopamine receptor availability--an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients. Schizophr Res (1998) 1.12
Gender differences in cerebral blood flow as a function of cognitive state with PET. J Nucl Med (1996) 1.11
Localized echo-volume imaging methods for functional MRI. J Magn Reson Imaging (1997) 1.11
Cerebellar pathology in schizophrenia: a controlled postmortem study. Am J Psychiatry (1980) 1.11
Cerebral ventricular size in major depressive disorder: association with delusional symptoms. Biol Psychiatry (1983) 1.11
Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. Am J Psychiatry (1989) 1.11
Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Biol Psychiatry (1998) 1.10
Brain disease and psychiatric illness: when should a psychiatrist order a CAT scan? Am J Psychiatry (1984) 1.10